Market Closed - Euronext Bruxelles 11:35:08 2024-02-26 am EST 5-day change 1st Jan Change
43.8 EUR -1.68% Intraday chart for Gimv NV +0.69% -1.13%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Onera Health, Inc. announced that it has received $32 million in funding from a group of investors CI
Onera Technologies B.V. announced that it has received ?30 million in funding from Gimv NV, EQT Life Sciences, Innovation Industries Management B.V., 15th Rock Ventures LLP, Invest-NL, Imec.xpand and another investor CI
Gimv, Akiles Invest in Sealing Products Producer Castelein Sealants MT
Castelein Sealants announced that it has received funding from Gimv NV, Akiles CI
Gimv, Paragon Partners Divest 100% of Wemas to Sekisui Jushi MT
Gimv: exit from the capital of Wemas CF
Gimv: arrival of a new reference shareholder CF
WorxInvest NV signed an agreement to acquire 27.81% stake in Gimv NV from Flemish Community for approximately ?370 million. CI
Gimv: share price stands out after 'solid' half-year results CF
Gimv NV Reports Earnings Results for the Half Year Ended September 30, 2023 CI
Crédit Mutuel Equity signed an agreement to acquire unknown majority stake in Groupe CLAIRE SAS from Gimv NV. CI
Arcus European Infrastructure Fund 3 Scsp managed by Arcus Infrastructure Partners LLP acquired majority stake in Coolworld Investments B.V. from Gimv NV. CI
ERS electronic GmbH announced that it has received funding from Gimv NV CI
Gimv NV Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Gimv NV acquired unknown majority stake in Witec Fijnmechanische Techniek B.V. CI
Complement Therapeutics Ltd announced that it has received €72 million in funding from a group of investors CI
Foundry Innovation & Research 1, Ltd. announced that it has received €23.7 million in funding from a group of investors CI
Paleo B.V. announced that it has received €12 million in funding from Gimv NV, SFPIM-International, DSM Venturing B.V., Siddhi Capital, LLC, Planet A GmbH, Beyond Impact, LLC CI
Lenaerts NV announced that it has received funding from Gimv NV CI
Mediar Therapeutics, Inc. announced that it has received $85.034866 million in funding from a group of investors CI
Cristallo TopCo announced that it has received funding from Gimv NV CI
Belgium's Gimv Invests in German Engineering Group Rohrleitungsbau Münster MT
Rohrleitungsbau Münster GmbH & Co. KG announced that it has received funding from Gimv NV CI
GIMV Exits French Clinical Testing Laboratories Group Biolam MT
Management of Biolam acquired an unknown minority stake in Biolam from Gimv NV. CI
Chart Gimv NV
More charts
Gimv NV is one of the leading investment companies in Belgium. At the end of March 2022, the portfolio had an estimated market value of EUR 1,522.9 million broken down by type of shares as follows: - investments in unlisted companies (74.2%); - investments in listed companies (3.5%); - other (22.3%). Portfolio breaks down geographically by value as follows: Belgium (27.8%), Germany (23.3%), France (21.4%), the Netherlands (18.6%), and RoW (8.9%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
44.55 EUR
Average target price
49.67 EUR
Spread / Average Target
+11.49%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Gimv NV - Euronext Bruxelles
  4. News Gimv NV
  5. Gimv to Invest in Expansion of Swiss Outpatient Mental Care Provider Les Psy Réunis
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW